drugset / Trial / NCT00198497

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

NCT00198497 ↗

Phase 3 Completed 510 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if intravitreal injection of Vitrase (ovine hyaluronidase) clears vitreous hemorrhage

Timeline

Start
1999-06
Primary completion
2001-09
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 55 iu Intravitreal
Subject HYALURONIDASE (OVINE) Protein / enzyme biologic 75 iu Intravitreal

Indications